Home
Cardiology
Emergency Medicine
Hematology-Oncology
Pediatrics
Pulmonology-Critical Care
New Content
edit
Get The App!
Go
Login
Register
Go
Home
Certified Programs
Non-Certified Programs
Quiz Challenge
IMPACT Live
Cardiology
Certified Programs
Non-Certified Programs
Quiz Challenge
IMPACT Live
Slides & Resources
Emergency Medicine
Certified Programs
Non-Certified Programs
Quiz Challenge
IMPACT Live
Slides & Resources
Hematology-Oncology
Certified Programs
Non-Certified Programs
Quiz Challenge
IMPACT Live
Slides & Resources
Pediatrics
Certified Programs
Non-Certified Programs
Quiz Challenge
Video Archive
Slides & Resources
Pulmonology-Critical Care
Certified Programs
Non-Certified Programs
Quiz Challenge
Video Archive
IMPACT Live
Slides & Resources
Hematology-Oncology
Certified Programs
Non-Certified Programs
Quiz Challenge
IMPACT Live
Slides & Resources
Featured Programs
Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors
7 episodes - 1.25 credit hours
Various Speakers
Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types
9 episodes - 2.25 credit hours
Various Speakers
The Evolving Role of Checkpoint Inhibitors as Frontline Treatment for Malignant Pleural Mesothelioma
7 episodes - 1.00 credit hours
Patrick Forde, MBBCh & Joshua Reuss, MD
Advances in Castrate-Resistant Prostate Cancer (CRPC): Integrating Data into Clinical Practice
6 episodes - 1.00 credit hours
Various Speakers
Test Your Knowledge:
Recognizing and Managing Immunotherapy Related Adverse Events
See More Quizzes
Featured Areas of Interest
Best Practices During COVID-19
2 items
Translating CAT Guidelines into Everyday Practice During COVID-19
8 episodes - 1.25 credit hours
Various Speakers
"Best Practice" Information During the Rapidly Evolving Era of COVID-19
11 episodes - 2.00 credit hours
Various Speakers
Immuno-Oncology
View All (21)
Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors
7 episodes - 1.25 credit hours
Various Speakers
Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types
9 episodes - 2.25 credit hours
Various Speakers
The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Gastric Cancer
6 episodes - 1.00 credit hour
Various Speakers
Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data into Practice
11 episodes - 2.25 credit hours
Various Speakers
Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into Practice
7 episodes - 1.50 credit hours
Various Speakers
Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into Clinical Practice
6 episodes - 1.00 credit hour
Various Speakers
Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021 Meeting into Clinical Practice
7 episodes - 1.00 credit hour
Various Speakers
Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting - Integrating Data into Clinical Practice
9 episodes - 1.25 credit hours
Various Speakers
The Evolving Role of Checkpoint Inhibitors as Frontline Treatment for Malignant Pleural Mesothelioma
7 episodes - 1.00 credit hour
Patrick Forde, MBBCh & Joshua Reuss, MD
IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma (HCC)
5 episodes - 1.00 credit hour
Various Speakers
Advancing the Care of ß-thalassemia Patients with Novel Therapies
14 episodes - 1.75 credit hours
Various Speakers
Impacting Patient Outcomes in mRCC
9 episodes - 1.50 credit hours
Various Speakers
Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
Ushering in Maintenance Therapy for AML
11 episodes - 1.75 credit hours
Various Speakers
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various Speakers
Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS
8 episodes - 1.25 credit hours
Various Speakers
Contemporary Challenges and New Approaches in Metastatic Melanoma
9 episodes - 1.75 credit hours
Various Speakers
New and Emerging Approaches to Managing Lower-Risk MDS
10 episodes - 2.00 credit hours
Various Speakers
IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)
13 episodes - 2.00 credit hours
Various Speakers
Frontline Systemic Therapy for Metastatic Melanoma
7 episodes - 1.00 credit hour
Various Speakers
Gastrointestinal Cancers (GI)
View All (7)
Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors
7 episodes - 1.25 credit hours
Various Speakers
Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types
9 episodes - 2.25 credit hours
Various Speakers
The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Gastric Cancer
6 episodes - 1.00 credit hour
Various Speakers
Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into Practice
7 episodes - 1.50 credit hours
Various Speakers
IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma (HCC)
5 episodes - 1.00 credit hour
Various Speakers
Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
Genitourinary Cancers (GU)
View All (10)
Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types
9 episodes - 2.25 credit hours
Various Speakers
Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data into Practice
11 episodes - 2.25 credit hours
Various Speakers
Advances in Castrate-Resistant Prostate Cancer (CRPC): Integrating Data into Clinical Practice
6 episodes - 1.00 credit hour
Various Speakers
Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into Clinical Practice
6 episodes - 1.00 credit hour
Various Speakers
Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021 Meeting into Clinical Practice
7 episodes - 1.00 credit hour
Various Speakers
Impacting Patient Outcomes in mRCC
9 episodes - 1.50 credit hours
Various Speakers
Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC
6 episodes - 1.25 credit hours
Various Speakers
Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19 Consideration
5 episodes - 1.00 credit hour
Various Speakers
TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal Cell Carcinoma (mccRCC)
13 episodes - 2.00 credit hours
Various Speakers
Bone Marrow/Stem Cell Transplantation
View All (6)
Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting - Integrating Data into Clinical Practice
9 episodes - 1.25 credit hours
Various Speakers
Advancing the Care of ß-thalassemia Patients with Novel Therapies
14 episodes - 1.75 credit hours
Various Speakers
Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice
12 episodes - 2.00 credit hours
Various Speakers
Ushering in Maintenance Therapy for AML
11 episodes - 1.75 credit hours
Various Speakers
Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS
8 episodes - 1.25 credit hours
Various Speakers
New and Emerging Approaches to Managing Lower-Risk MDS
10 episodes - 2.00 credit hours
Various Speakers
Anticoagulation Management & Reversal
View All (7)
The Bleeding Patient in the Emergency Department, Evidence-Based Approaches
2 episodes - 0.50 credit hours
Natalie Kreitzer, MD, MS
Managing Intracranial Hemorrhages in the Presence of Anticoagulation
3 episodes - 0.50 credit hours
Fred Rincon, MD, MSc, MBE
Case Studies in Hemorrhagic Stroke Management - What Should be Done?
4 episodes - 0.50 credit hours
Anmar Razak, MD
Time is Brain: The Management of Hemorrhagic Strokes and Role of Comprehensive Stroke Centers
7 episodes - 1.00 credit hour
Various Speakers
Translating CAT Guidelines into Everyday Practice During COVID-19
8 episodes - 1.25 credit hours
Various Speakers
Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients – Part 2
10 episodes - 1.00 credit hour
Various Speakers
Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients
12 episodes - 1.50 credit hours
Various Speakers